Spots Global Cancer Trial Database for A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer
Official Title: A Phase IIb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell Inj.) or Topotecan in Patients With Relapsed Small Cell Lung Cancer
Study ID: NCT01497873
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of Belotecan administered 5 days every 3 weeks in comparison to Topotecan in Patients with relapsed small cell lung cancer.
Detailed Description: A Phase Ⅱb, Randomized, Open, Parallel-Group, Multi-Center Trial to Assess the Efficacy and Safety of Belotecan(CamtoBell inj.) or Topotecan in Patients with Relapsed Small Cell Lung Cancer
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chungbuk University Hospital, Daegu, , Korea, Republic of
Keimyung University Dongsan Center, Daegu, , Korea, Republic of
National Cancer Center, Goyang, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
CHA Bundang Medical Center, Seoul, , Korea, Republic of
Chung-Ang University hospital, Seoul, , Korea, Republic of
Kyung Hee University Medical Hospital, Seoul, , Korea, Republic of
Seoul National University Boramae Medical Center, Seoul, , Korea, Republic of
Seoul National University Hospital, Seoul, , Korea, Republic of
Seoul St. Marys Hospital, Seoul, , Korea, Republic of
Seoul Veterans Hospital, Seoul, , Korea, Republic of
Yonsei Cancer Center, Seoul, , Korea, Republic of
Ajou University Hospital, Suwon, , Korea, Republic of
St. Vincents Hospital, Suwon, , Korea, Republic of
Contact Details
Name: Heung Tae Kim, M.D., Ph.D
Affiliation: National Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Name: Jin Hyoung Kang, M.D., Ph.D
Affiliation: The Catholic University of Korea Seoul St. Marys Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jin Young Kim, M.D., Ph.D
Affiliation: Keimyung University Dongsan Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Dong-Wan Kim, M.D., Ph.D
Affiliation: Seoul National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Sang-We Kim, M.D., Ph.D
Affiliation: Asan Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Hye Ryeon Kim, M.D., Ph.D
Affiliation: Yonsei Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Name: Jin Hyuk Choi, M.D., Ph.D
Affiliation: Ajou University School of Medicine
Role: PRINCIPAL_INVESTIGATOR
Name: Ki Hyeong Lee, M.D., Ph.D
Affiliation: Chungbuk National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Ho Jung An, M.D., Ph.D
Affiliation: St. Vincents Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Chi Hoon Maeng, M.D., Ph.D
Affiliation: Kyung Hee University Medical Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Jin-Soo Kim, M.D., Ph.D
Affiliation: SMG-SNU Boramae Medical Center
Role: PRINCIPAL_INVESTIGATOR
Name: Joung Soon Jang, M.D., Ph.D
Affiliation: Choung Ang University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Bong Seog Kim, M.D., Ph.D
Affiliation: Seoul Veterans Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Joo-Hang Kim, .D., Ph.D
Affiliation: CHA Bundang Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
